Skip to content
  • Home
  • About Us
  • Magazines
  • Articles
  • Contact Us
  • Home
  • About Us
  • Magazines
  • Articles
  • Contact Us
Subscribe
Web Series

From Bestseller to Blockbuster: First-Edition Success Ignites the Race for Film and Mega Web Series Rights 

Finally! – A Senapati with Nerves of Steel has emerged as far more than a successful debut novel.

Read More »
Healthcare Excellence

Celebrating Healthcare Excellence & Leadership Awards 2025: Honoring Visionaries Shaping the Future of Global Healthcare

Pune, India – October 2025 – Healthcare Excellence & Leadership Awards 2025 recognized and celebrated some of

Read More »
Virtual Clinical

The Promise and Pitfalls of Virtual Clinical Trials in the Digital Age

Digital Research In the era of smartphones tracking our steps, wearables tracking our heart rates,

Read More »
Clinical Trial

How Global Standards Shape Clinical Trial Success

Regulatory Roadmaps Clinical trials are the bedrock of medical progress, subjecting new medicines, treatments, and

Read More »
Oral Solid Dosage

Sustainability in Oral Solid Dosage Manufacturing

Green Practices for Pharma The pharmaceutical industry has a long history of being the cornerstone

Read More »
Oral Solid Dosage

Oral Solid Dosage vs. Other Delivery Systems

A Comparative Analysis The development and delivery of pharmaceutical agents will decisively depend on the

Read More »
Pharmanlifescience Magazine is a focused platform where pharmaceuticals and life sciences meet, bringing you the stories that truly matter…Read More

© 2026 PHARMANLIFESCIENCE MAG. All Rights Reserved

Quick Links

  • Home
  • About Us
  • Magazines
  • Articles
  • Contact Us
  • Home
  • About Us
  • Magazines
  • Articles
  • Contact Us

Latest Posts

AstraZeneca to Invest $15 Billion in China to Boost Drug Research and Manufacturing

AstraZeneca to Invest $15 Billion in China to Boost Drug Research and Manufacturing

CSPC Pharma Signs $1.2 Billion Peptide Drug Deal With AstraZeneca

CSPC Pharma Signs $1.2 Billion Peptide Drug Deal With AstraZeneca

Insilico Medicine and Qilu Pharmaceutical Partner to Develop New Treatments for Metabolic Diseases

Insilico Medicine and Qilu Pharmaceutical Partner to Develop New Treatments for Metabolic Diseases

Janux Therapeutics Signs Up to $850 Million Cancer Drug Partnership With Bristol Myers Squibb

Janux Therapeutics Signs Up to $850 Million Cancer Drug Partnership With Bristol Myers Squibb